The efficiency and mechanism of a new absorption enhancer, malic acid, for enhancing the oral bioavailability of docetaxel

References

• Alama T, Katayama H, Hirai S, Ono S, Kajiyama A, Kusamori K, Katsumi H, Sakane T, Yamamoto A. 2016. Enhanced oral delivery of alendronate by sucrose fatty acids esters in rats and their absorption-enhancing mechanisms. Int J Pharm. 515(1–2):476–489.
   PubMedGoogle Scholar
• Anderski J, Mahlert L, Mulac D, Langer K. 2018. Mucus-penetrating nanoparticles: promising drug delivery systems for the photodynamic therapy of intestinal cancer. Eur J Pharm Biopharm. 129:1–9.
   PubMed Web of Science ®Google Scholar
• Bu X, Zhu T, Ma Y, Shen Q. 2015. Co-administration with cell penetrating peptide enhances the oral bioavailability of docetaxel-loaded nanoparticles. Drug Dev Ind Pharm. 41(5):764–771.
   PubMed Web of Science ®Google Scholar
• Chen MC, Mi FL, Liao ZX, Hsiao CW, Sonaje K, Chung MF, Hsu LW, Sung HW. 2013. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules. Adv Drug Deliv Rev. 65(6):865–879.
   PubMed Web of Science ®Google Scholar
• Dalmoro A, Bochicchio S, Nasibullin SF, Bertoncin P, Lamberti G, Barba AA, Moustafine RI. 2018. Polymer-lipid hybrid nanoparticles as enhanced indomethacin delivery systems. Eur J Pharm Sci. 121:16–28.
   PubMed Web of Science ®Google Scholar
• Ganesan P, Ramalingam P, Karthivashan G, Ko YT, Choi DK. 2018. Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases. Int J Nanomedicine. 13:1569–1583.
   PubMed Web of Science ®Google Scholar
• Gourdon B, Chemin C, Moreau A, Arnauld T, Delbos JM, Pean JM, Decleves X. 2018. Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter PepT1 targeting and oxytocin transport. Eur J Pharm Biopharm. 129:122–133.
   PubMed Web of Science ®Google Scholar
• Guo XH, Chen CP, Liu X, Hou PP, Guo XN, Ding F, Wang ZH, Hu YR, Li Z, Zhang ZZ. 2017. High oral bioavailability of 2-methoxyestradiol in PEG-PLGA micelles-microspheres for cancer therapy. Eur J Pharm Biopharm. 117:116–122.
   PubMed Web of Science ®Google Scholar
• Guo X, Cui F, Xing Y, Mei Q, Zhang Z. 2011. Investigation of a new injectable thermosensitive hydrogel loading solid lipid nanoparticles. Pharmazie. 66(12):948–952.
   PubMed Web of Science ®Google Scholar
• Guo X, Xing Y, Mei Q, Zhang H, Zhang Z, Cui F. 2012. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles. Anticancer Drugs. 23(2):185–190.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhang X, Ye L, Zhang Y, Ding R, Hao Y, Zhao Y, Zhang Z, Zhang Y. 2014. Inhalable microspheres embedding chitosan-coated PLGA nanoparticles for 2-methoxyestradiol. J Drug Target. 22(5):421–427.
   PubMed Web of Science ®Google Scholar
• Hao T, Ling Y, Wu M, Shen Y, Gao Y, Liang S, Gao Y, Qian S. 2017. Enhanced oral bioavailability of docetaxel in rats combined with myricetin: in situ and in vivo evidences. Eur J Pharm Sci. 101:71–79.
   PubMed Web of Science ®Google Scholar
• Huckaby JT, Lai SK. 2018. PEGylation for enhancing nanoparticle diffusion in mucus. Adv Drug Deliv Rev. 124:125–139.
   PubMed Web of Science ®Google Scholar
• Jini T, Saban KV, Varghese G. 2005. Thermal and infrared studies of calcium malate crystals grown in diffusion limited medium. Cryst Res Technol. 40(12):1155–1159.
   Web of Science ®Google Scholar
• Ju L, Cailin F, Wenlan W, Pinghua Y, Jiayu G, Junbo L. 2017. Preparation and properties evaluation of a novel pH-sensitive liposomes based on imidazole-modified cholesterol derivatives. Int J Pharm. 518(1–2):213–219.
   PubMedGoogle Scholar
• Kuppens IE, Bosch TM, van Maanen MJ, Rosing H, Fitzpatrick A, Beijnen JH, Schellens JH. 2005. Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093). Cancer Chemother Pharmacol. 55(1):72–78.
   PubMed Web of Science ®Google Scholar
• Lai SK, O’Hanlon DE, Harrold S, Man ST, Wang YY, Cone R, Hanes J. 2007. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci USA. 104(5):1482–1487.
   PubMed Web of Science ®Google Scholar
• Li X, Uehara S, Sawangrat K, Morishita M, Kusamori K, Katsumi H, Sakane T, Yamamoto A. 2018. Improvement of intestinal absorption of curcumin by cyclodextrins and the mechanisms underlying absorption enhancement. Int J Pharm. 535(1–2):340–349.
   PubMed Web of Science ®Google Scholar
• Manconi M, Marongiu F, Castangia I, Manca ML, Caddeo C, Tuberoso CI, D’Hallewin G, Bacchetta G, Fadda AM. 2016. Polymer-associated liposomes for the oral delivery of grape pomace extract. Colloids Surf B Biointerfaces. 146:910–917.
   PubMed Web of Science ®Google Scholar
• Nassar T, Attili-Qadri S, Harush-Frenkel O, Farber S, Lecht S, Lazarovici P, Benita S. 2011. High plasma levels and effective lymphatic uptake of docetaxel in an orally available nanotransporter formulation. Cancer Res. 71(8):3018–3028.
   PubMed Web of Science ®Google Scholar
• Ni J, Tian F, Dahmani FZ, Yang H, Yue D, He S, Zhou J, Yao J. 2016. Curcumin-carboxymethyl chitosan (CNC) conjugate and CNC/LHR mixed polymeric micelles as new approaches to improve the oral absorption of P-gp substrate drugs. Drug Deliv. 23(9):3424–3435.
   PubMed Web of Science ®Google Scholar
• Niklander S, Fuentes F, Sanchez D, Araya V, Chiappini G, Martinez R, Marshall M. 2018. Impact of 1% malic acid spray on the oral health-related quality of life of patients with xerostomia. J Oral Sci. 60(2):278–284.
   PubMed Web of Science ®Google Scholar
• Song CK, Yoon IS, Kim DD. 2016. Poloxamer-based solid dispersions for oral delivery of docetaxel: differential effects of F68 and P85 on oral docetaxel bioavailability. Int J Pharm. 507(1–2):102–108.
   PubMed Web of Science ®Google Scholar
• Wang YY, Lai SK, Suk JS, Pace A, Cone R, Hanes J. 2008. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that “slip” through the human mucus barrier. Angew Chem Int Ed Engl. 47(50):9726–9729.
   PubMed Web of Science ®Google Scholar
• Xing Y, Liu X, Li X, Ding F, Zhang J, Guo X. 2019. PEG-PCL modification and intestinal sustained-release of solid lipid nanoparticles for improving oral bioavailability of 2-methoxyestradiol. J Liposome Res. 29(3):207–214.
   PubMed Web of Science ®Google Scholar
• Yang M, Chen T, Wang L, Chen L, Li J, Di L. 2018. High dispersed phyto-phospholipid complex/TPGS 1000 with mesoporous silica to enhance oral bioavailability of tanshinol. Colloids Surf B Biointerfaces. 170:187–193.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu W, Zhang H, Han J, Zhang L, Lin Q, Ai F. 2017. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel. Int J Pharm. 532(1):384–392.
   PubMedGoogle Scholar